Subramanian, Saravanan, Magendran Rajendiran, Maheshwari Paramasivam, Indhupriyadharshini Murugesan, Shanmugasundaram Palani, and Sivakumar Velusamy. 2026. “Advances in SGLT2 Inhibitor Therapy: Comparative Evidence for Empagliflozin and Dapagliflozin in Cardio-Renal-Metabolic Disorders”. International Journal of Advancement in Life Sciences Research 9 (4), 56-68. https://doi.org/https://doi.org/10.31632/ijalsr.2026.v09i04.004.